name: Lymphocyte proliferation. 0.125 ug pokeweed mitogen stimulation:NRat:Pt:Bld:Qn


name: Lymphocyte proliferation. 0.25 ug pokeweed mitogen stimulation:NRat:Pt:Bld:Qn


name: Lymphocyte proliferation. 1.0 ug phytohemagglutinin stimulation:NRat:Pt:Bld:Qn


name: Lymphocyte proliferation. 1.0 ug pokeweed mitogen stimulation:ACnc:Pt:Bld:Qn


name: Lymphocyte proliferation. 10 ug concanavalin A stimulation:NRat:Pt:Bld:Qn


name: Bathing - support provided during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Resident believes he or she is capable of increased independence in at least some ADLs:Find:Pt:^Patient:Ord:MDS


name: Direct care staff believe resident is capable of increased independence in at least some ADLs:Find:Pt:^Patient:Ord:CMS Assessment


name: Resident able to perform tasks or activity but is very slow:Find:Pt:^Patient:Ord:MDS


name: Difference in ADL Self-Performance or ADL Support, comparing mornings to evenings:Find:Pt:^Patient:Ord:MDS


name: Activities of daily living rehabilitation potential - none of above:Find:Pt:^Patient:Ord:MDS


name: Recurrent lung aspirations in last 90D:Find:90D:^Patient:Ord:MDS


name: Mycoplasma sp DNA:PrThr:Pt:Body fld:Ord:Probe.amp.tar


name: Influenza virus B Ag:PrThr:Pt:Nph:Ord:IF


name: Influenza virus B Ag:PrThr:Pt:Bronchial:Ord:IF


name: Influenza virus B Ag:PrThr:Pt:Nose:Ord:IF


name: Influenza virus B Ag:PrThr:Pt:Trac:Ord:IF


name: Influenza virus B Ag:PrThr:Pt:Nose:Ord:IA


name: Influenza virus B Ag:PrThr:Pt:Bronchial:Ord


name: Influenza virus C Ab:PrThr:Pt:Ser:Ord:Comp fix


name: HTLV I+II p21 env Ab:PrThr:Pt:Ser:Ord:IB


name: HTLV I+II p38 tax Ab:PrThr:Pt:Ser:Ord:IB


name: ALOX3+ALOX12B gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: KCNQ1 gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: PWS gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Total linear mm of carcinoma:Len:Pt:Specimen:Qn


name: Length of tissue core(s):Len:Pt:Specimen:Qn


name: Regional lymph nodes examined CAP (Spec) [#]


name: Regional lymph nodes containing metastases CAP (Spec) [#]


name: Matted nodes:Prid:Pt:Specimen:Nom:CAP cancer protocols


name: Seminal vesicle invasion:Prid:Pt:Specimen:Nom:CAP cancer protocols


name: Extraprostatic extension:Prid:Pt:Prostate tumor:Nom:CAP cancer protocols


name: Reason specimen size cannot be determined:Find:Pt:Breast tumor:Nar


name: Specimen size.max dimension:Len:Pt:Breast tumor:Qn


name: Specimen size.additional dimension 1:Area:Pt:Breast tumor:Qn


name: Specimen size.additional dimension 2:Area:Pt:Breast tumor:Qn


name: Satellite nodule presence CAP Nom (Skin melanoma)


name: Reason invasive component size cannot be determined:Find:Pt:Breast tumor:Nar


name: Invasive component size.max.dimension:Len:Pt:Breast tumor:Qn


name: Invasive component size.additional dimension 1:Len:Pt:Breast tumor:Qn


name: Invasive component size.additional dimension 2:Len:Pt:Breast tumor:Qn


name: Nottingham mitotic count.25x obj CAP Nom (Breast tumor)


name: Nottingham mitotic count.40x obj CAP Nom (Breast tumor)


name: Histologic grade:Score:Pt:Breast cancer specimen:SemiQn:Nottingham


name: Mitotic count per 10 HPF:Area:Pt:Breast tumor:Qn


name: Total number of cores:Num:Pt:Tissue core:Qn


name: Tumor quantitation.incidental:Find:Pt:Prostate tumor:Nom:CAP cancer protocols


name: Prostatic tissue involved by tumor:NFr:Pt:Prostate tumor:Qn


name: Number of tissue chips:Num:Pt:Tissue chip:Qn


name: Dominant nodule.additional dimension 1:Len:Pt:Prostate tumor:Qn


name: Tumor involved by ulceration:Prid:Pt:Skin melanoma:Nom:CAP cancer protocols


name: Depth of invasion by tumor:Len:Pt:Skin melanoma:Qn


name: Depth of invasion by tumor cannot be determined comment:Find:Pt:Skin melanoma:Nar


name: T classification CAP Nom (Prostate tumor)


name: T classification CAP Nom (Skin melanoma)


name: M stage of distant metastasis CAP Ql (Breast tumor)


name: Site of distant metastasis:Find:Pt:Breast tumor:Nom


name: M stage of distant metastasis CAP Ql (Skin melanoma)


name: Margin(s) involved by invasive melanoma:Find:Pt:Skin melanoma:Nom


name: Margin(s) involved by melanoma in situ:Find:Pt:Skin melanoma:Nom


name: Invasive melanoma.uninvolved margin.closest:Find:Pt:Skin melanoma:Nom


name: Invasive melanoma in situ.uninvolved margin.closest:Find:Pt:Skin melanoma:Nom


name: Distance of invasive melanoma to closest lateral margin:Len:Pt:Skin melanoma:Qn


name: Distance of melanoma in situ to closest lateral margin:Len:Pt:Skin melanoma:Qn


name: Distance of invasive melanoma to closest deep margin:Len:Pt:Skin melanoma:Qn


name: Invasive melanoma.location relative to closest uninvolved lateral margin:Find:Pt:Skin melanoma:Nom


name: Melanoma in situ.location relative to closest uninvolved lateral margin:Find:Pt:Skin melanoma:Nom


name: Invasive melanoma.location relative to involved lateral margin:Find:Pt:Skin melanoma:Nom


name: Melanoma in situ.location relative to involved lateral margin:Find:Pt:Skin melanoma:Nom


name: Invasive melanoma.location relative to closest uninvolved deep margin:Find:Pt:Skin melanoma:Nom


name: Invasive melanoma.location relative to involved deep margin:Find:Pt:Skin melanoma:Nom


name: Tumor infiltrating lymphocytes:Find:Pt:Skin melanoma:Nom


name: Tumor regression:Find:Pt:Skin melanoma:Nom:CAP cancer protocols


name: Mitotic index:Find:Pt:Skin melanoma:Nom:CAP cancer protocols


name: Lesion size.additional dimension 1:Area:Pt:Skin:Qn


name: Extent of margin involvement CAP Nom (Cancer)


name: ACTA1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: BHD gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: MC4R gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: NEB gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: ALS4 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Nuclear Ab:PrThr:Pt:Ser:Ord:IF rat kidney substrate


name: Nuclear Ab:ACnc:Pt:Ser:Qn:IF rat kidney substrate


name: Hepatitis D virus Ag:PrThr:Pt:Ser:Ord:IA


name: Blood product units given:Num:Pt:^BPU:Qn


name: Model for end-stage liver disease score:Score:Pt:^Patient:Qn


name: Native inferior vena cava liver graft attachment:Type:Pt:^Patient:Nom


name: Liver transplant anastomosis site:Anat:Pt:Portal vein^Graft:Nom


name: Time cross clamp applied:TmStp:Pt:{Organ}:Qn


name: Time removed from cold:TmStp:Pt:{Organ}:Qn


name: Functional status of graft:Find:Pt:{Graft}:Nom


name: Cause of graft failure:Find:Pt:{Graft}:Nom


name: Alanine aminotransferase:CCnc:Stdy^max:Ser/Plas:Qn:No addition of P-5'-P


name: Amylase & Creatinine clearance panel:-:Pt:Urine+Ser/Plas:Qn


name: Immunoglobulin light chains panel:-:Pt:Urine:Qn


name: Immunoglobulin light chains panel:MCnc:Pt:Ser:Qn


name: Aquaporin 4 water channel Ab.IgG:Titr:Pt:Ser/Plas:SemiQn:IF


name: Influenza virus A H5 Asian RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Brucella sp:PrThr:Pt:XXX:Ord:Organism specific culture


name: Burkholderia sp identified:Prid:Pt:XXX:Nom:Organism specific culture


name: Coxiella burnetii:PrThr:Pt:XXX:Ord:Organism specific culture


name: Chlamydia trachomatis+Neisseria gonorrhoeae DNA:PrThr:Pt:Urine:Ord:Probe.amp.tar


name: Chlamydia trachomatis+Neisseria gonorrhoeae DNA:PrThr:Pt:Genital:Ord:Probe.amp.tar


name: Histoplasma capsulatum H Ab band pattern:Imp:Pt:Ser:Nom:IB


name: Histoplasma capsulatum M Ab band pattern:Imp:Pt:Ser:Nom:IB


name: Hepatitis C virus c22p Ab:PrThr:Pt:Ser:Ord:IB


name: Coxiella burnetii phase 2 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Hepatitis D virus Ab.IgM:ACnc:Pt:Ser:Qn:IA


name: Hepatitis C virus c100p+5-1-1 Ab:PrThr:Pt:Ser:Ord


name: Glycogen synthase I/Glycogen synthase.total:CFr:Pt:Bld:Qn


name: Acid phosphatase.tartrate resistant:PrThr:Pt:Bone mar:Ord


name: Mycobacterium sp identified^^^2:Prid:Pt:XXX:Nom:Organism specific culture


name: Mycobacterium sp identified^^^3:Prid:Pt:XXX:Nom:Organism specific culture


name: Mycobacterium sp identified^^^4:Prid:Pt:XXX:Nom:Organism specific culture


name: Mycobacterium sp identified^^^5:Prid:Pt:XXX:Nom:Organism specific culture


name: Iron.microscopic observation:PrThr:Pt:Body fld:Ord:XXX stain


name: Herpes simplex virus 1+2 DNA:PrThr:Pt:Vag:Ord:Probe.amp.tar


name: HIV 1 proviral DNA:PrThr:Pt:Bld:Ord:Probe.amp.tar


name: HIV 1 p24 Ag:PrThr:Pt:Ser/Plas^Donor:Ord:IA


name: Staphylococcus aureus enterotoxin A sea gene:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Staphylococcus aureus enterotoxin E see gene:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Staphylococcus aureus enterotoxin B seb gene:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Staphylococcus aureus toxic shock syndrome toxin gene:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Malignant cells:NCnc:Pt:Plr fld:Qn:Manual count


name: Malignant cells:NCnc:Pt:Synv fld:Qn:Manual count


name: Malignant cells:NCnc:Pt:Pericard fld:Qn:Manual count


name: Malignant cells:NCnc:Pt:Periton fld:Qn:Manual count


name: Malignant cells/100 cells:NFr:Pt:Synv fld:Qn


name: Malignant cells/100 cells:NFr:Pt:CSF:Qn:Manual count


name: Malignant cells/100 cells:NFr:Pt:Plr fld:Qn:Manual count


name: Malignant cells/100 cells:NFr:Pt:Synv fld:Qn:Manual count


name: Malignant cells/100 cells:NFr:Pt:Pericard fld:Qn:Manual count


name: Malignant cells/100 cells:NFr:Pt:Periton fld:Qn:Manual count


name: Malignant cells/100 cells:NFr:Pt:Urine:Qn:Manual count


name: Malignant cells/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Malignant cells/100 cells:NFr:Pt:Liver:Qn:Manual count


name: Malignant cells/100 cells:NFr:Pt:Plr fld:Qn


name: Malignant cells/100 cells:NFr:Pt:Bone mar:Qn


name: Malignant cells/100 cells:NFr:Pt:Pericard fld:Qn


name: Malignant cells/100 cells:NFr:Pt:Periton fld:Qn


name: Beta 2 globulin+Gamma globulin:MCnc:Pt:Ser/Plas:Qn:Electrophoresis


name: Beta 2 globulin+Gamma globulin/Protein.total:MFr:Pt:Ser/Plas:Qn:Electrophoresis


name: Prolactin^1.5H post dose TRH IV:ACnc:Pt:Ser/Plas:Qn


name: Prolactin^30M post dose TRH IV:ACnc:Pt:Ser/Plas:Qn


name: Prolactin^15M pre dose TRH IV:ACnc:Pt:Ser/Plas:Qn


name: Prolactin^2H post dose TRH IV:ACnc:Pt:Ser/Plas:Qn


name: Prolactin^pre dose TRH IV:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^15M post dose TRH IV:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^15M pre dose TRH IV:ACnc:Pt:Ser/Plas:Qn


name: Hepatitis D virus Ab.IgM:PrThr:Pt:Ser:Ord:IA


name: Alcoholic drinks per W:NRat:1W:^Patient:Qn:Reported


name: Barriers to self management:Find:Pt:^Patient:Ord


name: First nations living status:Find:Pt:^Family:Ord


name: Australian cervix cytology code:Imp:Pt:XXX:Nom


name: Borrelia burgdorferi 31kD Ab.IgG:PrThr:Pt:Ser:Ord:IB


name: Chlamydia trachomatis B Ab.IgM:PrThr:Pt:Ser:Ord


name: Chlamydia trachomatis B Ab.IgG:PrThr:Pt:Ser:Ord


name: Chlamydia trachomatis B Ab.IgA:PrThr:Pt:Ser:Ord


name: Chlamydia trachomatis Ab^2nd specimen:ACnc:Pt:Ser:Qn


name: Chlamydia trachomatis Ab^1st specimen:PrThr:Pt:Ser:Ord


name: Chlamydia trachomatis Ab:PrThr:Pt:Ser:Ord:Comp fix


name: Adenosine monophosphate.cyclic^2H post XXX challenge:SCnc:Pt:Urine:Qn


name: Adenosine monophosphate.cyclic^6H post XXX challenge:SCnc:Pt:Urine:Qn


name: Adenosine monophosphate.cyclic^4H post XXX challenge:SCnc:Pt:Urine:Qn


name: Adenosine monophosphate.cyclic/Creatinine^6H post XXX challenge:Ratio:Pt:Urine:Qn


name: Adenosine monophosphate.cyclic/Creatinine^2H post XXX challenge:Ratio:Pt:Urine:Qn


name: HLA typing for celiac disease panel:-:Pt:Bld/Tiss:-


name: HLA typing for narcolepsy panel:-:Pt:Bld:-


name: Bacteria producing arginine decarboxylase:PrThr:Pt:Isolate:Ord


name: Bacteria producing X & V factors:PrThr:Pt:Isolate:Ord


name: Time awake - none of above:Find:Pt:^Patient:Ord:MDS


name: Average time involved in activities:Find:Pt:^Patient:Ord:MDS


name: Preferred activity setting - own room:Find:Pt:^Patient:Ord:MDS


name: Preferred activity setting - inside NH &or off unit:Find:Pt:^Patient:Ord:MDS


name: Preferred activity setting - outside facility:Find:Pt:^Patient:Ord:MDS


name: Preferred activitty setting - none of above:Find:Pt:^Patient:Ord:MDS


name: Legionella pneumophila 2+3+4+5+6+8 Ab:Titr:Pt:Ser:SemiQn


name: Parainfluenza virus 1 Ab:Titr:Pt:CSF:SemiQn


name: Parainfluenza virus 3 Ab:PrThr:Pt:CSF:Ord


name: Psittacid herpesvirus 1 Ab:PrThr:Pt:Ser:Ord


name: Cardiolipin Ab.IgA & IgG & IgM panel:-:Pt:Ser:Qn


name: cycloSPORINE.monoclonal & polyclonal panel:MCnc:Pt:Bld:Qn


name: Spermatozoa Ab.IgA & IgG & IgM panel:-:Pt:Ser:-


name: Varicella zoster virus Ab.IgG & IgM panel:-:Pt:Ser:Qn


name: Deprecated Basic metabolic panel & Glomerular filtration rate.predicted


name: Deprecated Comprehensive metabolic panel & Glomerular filtration rate.predicted


name: Creatinine & Glomerular filtration rate.predicted panel:-:Pt:Ser/Plas/Bld:Qn


name: Chlamydia trachomatis+Neisseria gonorrhoeae DNA:PrThr:Pt:Cvx:Ord:Probe.amp.tar


name: Chlamydia trachomatis+Neisseria gonorrhoeae rRNA:PrThr:Pt:Genital:Ord:Probe


name: Chlamydia trachomatis+Neisseria gonorrhoeae rRNA:PrThr:Pt:Vag:Ord:Probe


name: C. trachomatis+N. gonorrhoeae rRNA Probe Ql (Penis)


name: Chlamydia trachomatis+Neisseria gonorrhoeae rRNA:PrThr:Pt:Anal:Ord:Probe


name: Chlamydia trachomatis+Neisseria gonorrhoeae rRNA:PrThr:Pt:Tiss:Ord:Probe


name: Chlamydia trachomatis+Neisseria gonorrhoeae rRNA:PrThr:Pt:Urine:Ord:Probe


name: Chlamydia trachomatis+Neisseria gonorrhoeae rRNA:PrThr:Pt:Urethra:Ord:Probe


name: Chlamydia trachomatis+Neisseria gonorrhoeae rRNA:PrThr:Pt:XXX:Ord:Probe


name: Chlamydia trachomatis:PrThr:Pt:Anal:Ord:Organism specific culture


name: Chlamydia trachomatis:PrThr:Pt:Cnjt:Ord:Organism specific culture


name: Chlamydia trachomatis:PrThr:Pt:Genital:Ord:Organism specific culture


name: Chlamydia trachomatis:PrThr:Pt:Nph:Ord:Organism specific culture


name: Chlamydia sp identified:Prid:Pt:Anal:Nom:Organism specific culture


name: Chlamydia sp identified:Prid:Pt:Cvx:Nom:Organism specific culture


name: Chlamydia sp identified:Prid:Pt:Body fld:Nom:Organism specific culture


name: Chlamydia sp identified:Prid:Pt:Vag:Nom:Organism specific culture


name: Chlamydia sp identified:Prid:Pt:Nph:Nom:Organism specific culture


name: Chlamydia sp identified Org specific cx Nom (Penis)


name: Chlamydia sp Ag:PrThr:Pt:Body fld:Ord:IF


name: Vesicular stomatitis Indiana virus Ag:PrThr:Pt:XXX:Ord:Comp fix


name: Vesicular stomatitis Indiana virus 1 Ab Neut test (S) [Titer]


name: Vesicular stomatitis Indiana virus Ag:PrThr:Pt:XXX:Ord:IA


name: Vesicular stomatitis Alagoas virus Ab.Neut:Titr:Pt:Ser:SemiQn:Neut


name: Vesicular stomatitis Alagoas virus Ag:PrThr:Pt:XXX:Ord:Comp fix


name: Vesicular stomatitis Alagoas virus Ag:PrThr:Pt:XXX:Ord:IA


name: Vesicular stomatitis New Jersey virus Ag:PrThr:Pt:XXX:Ord:IA


name: Vesicular stomatitis New Jersey virus Ag:PrThr:Pt:XXX:Ord:Comp fix


name: Human prescription drug label with highlights:-:-:^FDA product label:Nar


name: Chlamydia trachomatis Ab:PrThr:Pt:Body fld:Ord


name: Listeria monocytogenes O4b Ab.IgG:Titr:Pt:Ser:SemiQn


name: Listeria monocytogenes O4b Ab.IgM:Titr:Pt:Ser:SemiQn


name: Platelet associated Ab:PrThr:Pt:Bld:Ord:Flow cytometry


name: Platelet factor 4 heparin complex induced Ab:ACnc:Pt:Ser:Qn


name: U2 small nuclear ribonucleoprotein Ab.IgG:PrThr:Pt:Ser:Ord


name: Immune complex:ACnc:Pt:Ser/Plas:Qn:C3d binding assay


name: Hepatitis B virus & Hepatitis D virus Ab:Imp:Pt:Ser:Nar


name: Acremonium sp Ab:PrThr:Pt:Ser:Ord:Immune diffusion


name: Hepatitis B virus DNA:LnCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Escherichia coli O157 Ag:PrThr:Pt:Isolate:Ord:LA


name: Myelin associated glycoprotein Ab:ACnc:Pt:Ser:Qn:IF


name: Pancreatic islet cell Ab:ACnc:Pt:Ser:Qn:IF


name: HIV nucleoside reverse transcriptase gene mutations detected:Prid:Pt:Isolate:Nom


name: HIV nonnucleoside reverse transcriptase gene mutations detected:Prid:Pt:Isolate:Nom


name: Herpes gestationis Ab.IgG.non-complement fixing:PrThr:Pt:Ser:Ord:IF


name: Basement membrane zone Ab.IgG:PrThr:Pt:Ser:Ord:IF


name: Herpes gestationis Ab.IgG.complement fixing:PrThr:Pt:Ser:Ord:IF


name: Cow epithelium+Cow dander Ab.IgE:ACnc:Pt:Ser:Qn


name: Deprecated Ganglioside GD1a Ab [Presence] in Serum


name: Deprecated Ganglioside GQ1b Ab [Presence] in Serum


name: Glucose^3rd specimen post XXX challenge:MCnc:Pt:Urine:SemiQn:Test strip


name: Glucose^4th specimen post XXX challenge:MCnc:Pt:Urine:SemiQn:Test strip


name: Glucose^5th specimen post XXX challenge:MCnc:Pt:Urine:SemiQn:Test strip


name: Herpes simplex virus 2 Ab.IgM:PrThr:Pt:Ser:Ord:IF


name: Lymphocytic choriomeningitis virus Ab.IgG:PrThr:Pt:Ser:Ord


name: Lymphocytic choriomeningitis virus Ab.IgG:PrThr:Pt:CSF:Ord


name: Lymphocytic choriomeningitis virus Ab.IgM:PrThr:Pt:Ser:Ord


name: Lymphocytic choriomeningitis virus Ab.IgM:PrThr:Pt:CSF:Ord


name: Deprecated Moxifloxacin [Mass/volume] in Serum or Plasma


name: Pancreatic islet cell complement fixing Ab:Titr:Pt:Ser:SemiQn:IF


name: Chronic leukemia panel:-:Pt:XXX:-:Flow cytometry


name: Acute leukemia panel:-:Pt:XXX:-:Flow cytometry


name: Pregnancy associated plasma protein A multiple of the median:Prctl:Pt:Ser/Plas:SemiQn


name: Low molecular weight heparin induced platelet Ab:PrThr:Pt:Ser:Ord


name: Bacteria identified:Prid:Pt:Bld:Nom:Aerobic culture 25 deg C incubation


name: Bacteria identified:Prid:Pt:Bld:Nom:Anaerobic culture 25 deg C incubation


name: Lymphocytic choriomeningitis virus Ab.IgM:PrThr:Pt:Body fld:Ord


name: Lymphocytic choriomeningitis virus Ab.IgG:PrThr:Pt:Body fld:Ord


name: Influenza virus A+B Ab:PrThr:Pt:Body fld:Ord


name: DPYD gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Coxsackievirus B6 Ab:PrThr:Pt:Body fld:Ord


name: Coxsackievirus B5 Ab:PrThr:Pt:Body fld:Ord


name: Coxsackievirus B4 Ab:PrThr:Pt:Body fld:Ord


name: Coxsackievirus B3 Ab:PrThr:Pt:Body fld:Ord


name: Coxsackievirus B2 Ab:PrThr:Pt:Body fld:Ord


name: Coxsackievirus B1 Ab:PrThr:Pt:Body fld:Ord


name: Glucose^2.5H post 50 g lactose PO:SCnc:Pt:Ser/Plas:Qn


name: Glucose^45M post dose lactose PO:SCnc:Pt:Ser/Plas:Qn


name: FMR1 gene allele 1.CGG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: FMR1 gene allele 2.CGG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: Mycobacterium tuberculosis tuberculin stimulated gamma interferon:PrThr:Pt:Bld:Ord


name: FMR1 gene targeted mutation analysis:Find:Pt:Amnio fld:Doc:Molgen


name: NF1 gene targeted mutation analysis:Prid:Pt:Amnio fld:Nom:Molgen


name: NF2 gene targeted mutation analysis:Prid:Pt:Amnio fld:Nom:Molgen


name: Date skin test interpreted:TmStp:Pt:Skin:Qn


name: Time Rh immune globulin given:TmStp:Pt:^Patient:Qn


name: Lymphocyte proliferation. 20 ug concanavalin A stimulation:NRat:Pt:Bld:Qn


name: Lymphocyte proliferation. 0.5 ug phytohemagglutinin stimulation:NRat:Pt:Bld:Qn


name: Blood pressure systolic & diastolic^post phlebotomy:Pres:Pt:Arterial system:Qn


name: Time of transfusion reaction:TmStp:Pt:^Patient:Qn


name: None of the listed diseases or conditions:Find:Pt:^Patient:Ord:MDS


name: Infection with Clostridioides difficile:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol summary section:-:Pt:^Patient:-


name: Influenza virus A Ag:PrThr:Pt:Nph:Ord:IA


name: Influenza virus B Ag:PrThr:Pt:Nph:Ord:IA


name: Calcium phosphate crystals:Naric:Pt:Urine sed:Qn:Microscopy.light.LPF


name: Calcium carbonate crystals:Naric:Pt:Urine sed:Qn:Microscopy.light.LPF


name: Ability to understand others:Find:Pt:^Patient:Ord:MDS


name: Primary reason for assessment:Type:Pt:^Patient:Nom:MDS.basic


name: Codes for assessments required for Medicare PPS or the State:Type:Pt:^Patient:Nom:MDS


name: Admitted from (at entry):Type:Pt:Facility:Nom:MDS


name: Lived alone prior to admission:Find:Pt:^Patient:Ord:MDS


name: History of stay in other nursing home:Find:Pt:^Patient:Ord:MDS


name: History of stay in other residential facility:Find:Pt:^Patient:Ord:MDS


name: History of stay at mental health &or psychiatric setting:Find:Pt:^Patient:Ord:MDS


name: None of the listed prior residential settings:Find:Pt:^Patient:Ord:MDS


name: Deprecated Lifetime occupations [CMS Assessment]


name: No mental retardation and developmental disabilities:Find:Pt:^Patient:Ord:MDS


name: Other organic condition related to mental retardation and developmental disabilities:Find:Pt:^Patient:Ord:MDS


name: Mental retardation and developmental disabilities with no organic condition:Find:Pt:^Patient:Ord:MDS


name: Date background information form completed:Date:Pt:^Patient:Qn:MDS


name: Stays up late at night:Find:Pt:^Patient:Ord:MDS


name: Naps regularly during day:Find:Pt:^Patient:Ord:MDS


name: Goes out 1 or more D a W:Find:Pt:^Patient:Ord:MDS


name: Stays busy with hobbies, reading or fixed daily routine:Find:Pt:^Patient:Ord:MDS


name: Use of tobacco products at least daily:Find:Pt:^Patient:Ord:MDS


name: None of the listed cycle of daily events:Find:Pt:^Patient:Ord:MDS


name: Eats between meals all or most D:Find:Pt:^Patient:Ord:MDS


name: Use of alcohol at least weekly:Find:Pt:^Patient:Ord:MDS


name: None of the listed eating patterns:Find:Pt:^Patient:Ord:MDS


name: In bedclothes much of day:Find:Pt:^Patient:Ord:MDS


name: Has irregular bowel movement pattern:Find:Pt:^Patient:Ord:MDS


name: None of the listed additional ADL patterns:Find:Pt:^Patient:Ord:MDS


name: Daily contact with relatives &or close friends:Find:Pt:^Patient:Ord:MDS


name: Usually attends church, temple, etc.:Find:Pt:^Patient:Ord:MDS


name: Finds strength in faith:Find:Pt:^Patient:Ord:MDS


name: Daily animal companion &or presence:Find:Pt:^Patient:Ord:MDS


name: Involved in group activities:Find:Pt:^Patient:Ord:MDS


name: None of the listed involvement patterns:Find:Pt:^Patient:Ord:MDS


name: Unknown customary routine - resident &or family unable to provide information:Find:Pt:^Patient:Ord:MDS


name: Date of last day of MDS observation period:Date:Pt:^Patient:Qn:MDS


name: Original or corrected copy of form:Num:Pt:^Patient:Ord:MDS


name: Date of reentry to facility:Date:Pt:^Patient:Qn:MDS


name: Medicare ancillary part A:Find:Pt:^Patient:Ord:MDS


name: Medicare ancillary part B:Find:Pt:^Patient:Ord:MDS


name: Medicaid resident liability or Medicare copayment:Find:Pt:^Patient:Ord:MDS


name: Private insurance per diem:Find:Pt:^Patient:Ord:MDS


name: Health care durable power attorney:Find:Pt:^Patient:Ord:MDS


name: Financial durable power attorney:Find:Pt:^Patient:Ord:MDS


name: Patient responsible for self:Find:Pt:^Patient:Ord:MDS


name: Responsibility - none of above:Find:Pt:^Patient:Ord:MDS


name: Advance directive &or living will completed:Find:Pt:^Patient:Ord


name: Advance directive - do not resuscitate:Find:Pt:^Patient:Ord:MDS


name: Advance directive - do not hospitalize:Find:Pt:^Patient:Ord:MDS


name: Advance directive - organ donation:Find:Pt:^Patient:Ord:MDS


name: Advance directive - autopsy request:Find:Pt:^Patient:Ord:MDS


name: Advance directive - feeding restrictions:Find:Pt:^Patient:Ord:MDS


name: Advance directive - medication restrictions:Find:Pt:^Patient:Ord:MDS


name: Advance directive - none:Find:Pt:^Patient:Ord:MDS


name: Can recall current season:Find:Pt:^Patient:Ord:MDS


name: Can recall location of own room:Find:Pt:^Patient:Ord:MDS


name: Can recall staff names &or faces:Find:Pt:^Patient:Ord:MDS


name: Can recall that he or she is in nursing home:Find:Pt:^Patient:Ord:MDS


name: Memory &or recall - none of above are recalled:Find:Pt:^Patient:Ord:MDS


name: Cognitive skills for daily decision making:Find:Pt:^Patient:Ord:MDS


name: Periods of altered perception or awareness of surroundings:Find:Pt:^Patient:Ord:MDS


name: Episodes of disorganized speech:Find:Pt:^Patient:Ord:MDS


name: Mental function varies over the course of the day:Find:Pt:^Patient:Ord:MDS


name: Change in cognitive status:Find:Pt:^Patient:Ord:MDS


name: Hearing aid present & used:Find:Pt:^Patient:Ord:MDS


name: Hearing aid present & not used regularly:Find:Pt:^Patient:Ord:MDS


name: Other receptive communication techniques used:Find:Pt:^Patient:Ord:MDS


name: Uses written messages to express or clarify needs:Find:Pt:^Patient:Ord:MDS


name: Uses American sign language or Braille:Find:Pt:^Patient:Ord:MDS


name: Uses signs &or gestures &or sounds:Find:Pt:^Patient:Ord:MDS


name: Modes of expression - none of above:Find:Pt:^Patient:Ord:MDS


name: Sees halos or rings around lights, flashes of light, or curtains over eyes:Find:Pt:^Patient:Ord:MDS


name: Resident made negative statements:Find:Pt:^Patient:Ord:MDS


name: Persistent anger with self or others:Find:Pt:^Patient:Ord:MDS


name: Expression of what appear to be unrealistic fears:Find:Pt:^Patient:Ord:MDS


name: Recurrent statements that something terrible is about to happen:Find:Pt:^Patient:Ord:MDS


name: Balance while sitting - position, trunk control:Find:Pt:^Patient:Ord:MDS


name: Range of motion:Find:Pt:Upper extremity:Ord:MDS


name: Range of motion:Find:Pt:Lower extremity:Ord:MDS


name: Other limitation or loss - range of motion:Find:Pt:^Patient:Ord:MDS


name: Other limitation or loss - voluntary movement:Find:Pt:^Patient:Ord:MDS


name: Uses cane, walker or crutch:Find:Pt:^Patient:Ord:MDS


name: Wheelchair primary mode of locomotion:Find:Pt:^Patient:Ord:MDS


name: No modes of locomotion:Find:Pt:^Patient:Ord:MDS


name: Bedfast all or most of the time:Find:Pt:^Patient:Ord:MDS


name: Bed rails used for bed mobility or transfer:Find:Pt:^Patient:Ord:MDS


name: Repetitive anxious complaints or concerns:Find:Pt:^Patient:Ord:MDS


name: Unpleasant mood in morning:Find:Pt:^Patient:Ord:MDS


name: Insomnia &or change in sleeping pattern:Find:Pt:^Patient:Ord:MDS


name: Sad, pained, or worried facial expressions:Find:Pt:^Patient:Ord:MDS


name: Withdrawal from activities of interest:Find:Pt:^Patient:Ord:MDS


name: Frequency of verbally abusive behavioral symptoms:NRat:Pt:^Patient:Qn:MDS


name: Alterability of verbally abusive behavioral symptoms:Find:Pt:^Patient:Ord:MDS


name: Frequency of physically abusive behavioral symptoms:NRat:Pt:^Patient:Qn:MDS


name: Frequency of socially inappropriate or disruptive behavioral symptoms:NRat:Pt:^Patient:Qn:MDS


name: Alterability of socially inappropriate or disruptive behavioral symptoms:Find:Pt:^Patient:Ord:MDS


name: Frequency of resists care:NRat:Pt:^Patient:Qn:MDS


name: Alterability of resists care:Find:Pt:^Patient:Ord:MDS


name: Change in behavioral symptoms:Find:Pt:^Patient:Ord:MDS


name: At ease interacting with others:Find:Pt:^Patient:Ord:MDS


name: At ease doing planned or structured activities:Find:Pt:^Patient:Ord:MDS


name: At ease doing self-initiated activities:Find:Pt:^Patient:Ord:MDS


name: Pursues involvement in life of facility:Find:Pt:^Patient:Ord:MDS


name: Accepts invitations to most group activities:Find:Pt:^Patient:Ord:MDS


name: Sense of initiative - none of above:Find:Pt:^Patient:Ord:MDS


name: Covert &or open conflict with or repeated criticism of staff:Find:Pt:^Patient:Ord:MDS


name: Unhappy with residents other than roommate:Find:Pt:^Patient:Ord:MDS


name: Openly expresses conflict &or anger with family &or friends:Find:Pt:^Patient:Ord:MDS


name: Absence of contact with family &or friends:Find:Pt:^Patient:Ord:MDS


name: Recent loss of close family member &or friend:Find:Pt:^Patient:Ord:MDS


name: Does not adjust easily to change in routines:Find:Pt:^Patient:Ord:MDS


name: Expresses sadness &or anger &or empty feeling over lost roles &or status:Find:Pt:^Patient:Ord:MDS


name: Past roles - none of above:Find:Pt:^Patient:Ord:MDS


name: Bed mobility - self-performance during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Bed mobility - support provided during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Transfer - self-performance during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Transfer - support provided during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Walk in room - self-performance during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Walk in room - support provided during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Walk in corridor - self-performance during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Walk in corridor - support provided during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Locomotion on unit - self-performance during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Locomotion on unit - support provided during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Locomotion off unit - self-performance during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Dressing - self-performance during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Dressing - support provided during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Eating - self-performance during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Eating - support provided during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Toilet use - self-performance during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Toilet use - support provided during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Personal hygiene - self-performance during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Personal hygiene - support provided during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Bathing - self-performance during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Change in activities of daily living function:Find:Pt:^Patient:Ord:MDS


name: Bowel elimination pattern regular - at least one movement every three D:Find:Pt:^Patient:Ord:MDS


name: Bowel elimination pattern - none of above:Find:Pt:^Patient:Ord:MDS


name: Any scheduled toileting plan:Find:Pt:^Patient:Ord:MDS


name: Did not use toilet room &or commode &or urinal:Find:Pt:^Patient:Ord:MDS


name: Pads &or briefs used:Find:Pt:^Patient:Ord:MDS


name: Continence appliances and programs - none of above:Find:Pt:^Patient:Ord:MDS


name: Dementia other than Alzheimer's disease:Find:Pt:^Patient:Ord:MDS


name: Urinary tract infection in last 30D:Find:30D:^Patient:Ord:MDS


name: Other current or more detailed diagnoses & ICD9 codes:Prid:Pt:^Patient:Nom:MDS


name: Weight gain or loss of 3+ Lbs. within a 7D period:Find:7D:^Patient:Ord:MDS


name: Inability to lie flat due to shortness of breath:Find:Pt:^Patient:Ord:MDS


name: Insufficient fluid; did NOT consume all or almost all liquids provided during last 3D:Find:3D:^Patient:Ord:MDS


name: Problem conditions - none of above:Find:Pt:^Patient:Ord:MDS


name: Fell in past 30D:Find:30D:^Patient:Ord:MDS


name: Fell in past 31D-180D:Find:180D:^Patient:Ord:MDS


name: Hip fracture in last 180D:Find:180D:^Patient:Ord:MDS


name: Other fracture in last 180D:Find:180D:^Patient:Ord:MDS


name: Accidents - none of above:Find:Pt:^Patient:Ord:MDS


name: Conditions &or diseases make resident's cognitive, ADL, mood or behavior patterns unstable:Find:Pt:^Patient:Ord:MDS


name: Resident experiencing an acute episode or a flare-up of a recurrent or chronic problem:Find:Pt:^Patient:Ord:MDS


name: End-Stage disease, 6 or fewer Mo to live:Find:Pt:^Patient:Ord:MDS


name: Stability of conditions - none of above:Find:Pt:^Patient:Ord:MDS


name: Oral problems - none of above:Find:Pt:^Patient:Ord:MDS


name: Complains about the taste of many foods:Find:Pt:^Patient:Ord:MDS


name: Regular or repetitive complaints of hunger:Find:Pt:^Patient:Ord:MDS


name: Leaves 25%+ food uneaten at most meals:Find:Pt:^Patient:Ord:MDS


name: Nutritional problems - none of above:Find:Pt:^Patient:Ord:MDS


name: Syringe or oral feeding:Find:Pt:^Patient:Ord:MDS


name: Dietary supplement between meals:Find:Pt:^Patient:Ord:MDS


name: Plate guard, stabilized built-up utensil, etc.:Find:Pt:^Patient:Ord:MDS


name: On a planned weight change program:Find:Pt:^Patient:Ord:MDS


name: Nutritional approaches - none of above:Find:Pt:^Patient:Ord:MDS


name: Proportion of total calories received through parenteral or tube feeding in last 7D:Find:7D:^Patient:Ord:MDS


name: Deprecated Average fluid intake per day by IV or tube in last 7 days [Minimum Data Set]


name: Alcohol or drug treatment program:Find:Pt:^Patient:Ord


name: Alzheimer's or dementia special care unit:Find:Pt:^Patient:Ord:MDS


name: Training in skills required to return to the community:Find:Pt:^Patient:Ord:MDS


name: Special treatments &or programs - none of above:Find:Pt:^Patient:Ord:MDS


name: Total minutes of speech language pathology and audiology services in the last 7D:Time:7D:^Patient:Qn:MDS


name: Number of D with at least 15M of occupational therapy in the last 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Total minutes of occupational therapy in the last 7D:Time:7D:^Patient:Qn:MDS


name: Number of D with at least 15M of physical therapy in the last 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Total minutes of physical therapy in the last 7D:Time:7D:^Patient:Qn:MDS


name: Number of D with at least 15M of respiratory therapy in the last 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Total minutes of respiratory therapy in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Number of D with at least 15M of psychological therapy by any licensed mental health professional in the last 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Debris - soft, easily movable substances - present in mouth prior to going to bed at night:Find:Pt:^Patient:Ord:MDS


name: Has dentures or removable bridge:Find:Pt:^Patient:Ord:MDS


name: Some or all natural teeth lost but does not have or use dentures or partial plates:Find:Pt:^Patient:Ord:MDS


name: Broken, loose, or carious teeth:Find:Pt:^Patient:Ord:MDS


name: Inflamed, swollen, or bleeding gums, oral abscesses; ulcers or rashes:Find:Pt:^Patient:Ord:MDS


name: Daily cleaning of teeth or dentures or mouth care by resident or staff:Find:Pt:^Patient:Ord:MDS


name: Oral status &or disease prevention - none of above:Find:Pt:^Patient:Ord:MDS


name: Second or third degree burns:Find:Pt:^Patient:Ord:MDS


name: Open lesions other than ulcers, rashes, cuts:Find:Pt:^Patient:Ord:MDS


name: Skin desensitized to pain or pressure:Find:Pt:^Patient:Ord:MDS


name: Skin tears or cuts (other than surgery):Find:Pt:^Patient:Ord:MDS


name: Other skin problems - none of above:Find:Pt:^Patient:Ord:MDS


name: Pressure relieving devices for chair:Find:Pt:^Patient:Ord:MDS


name: Pressure relieving devices for bed:Find:Pt:^Patient:Ord:MDS


name: Turning or repositioning program:Find:Pt:^Patient:Ord:MDS


name: Nutrition or hydration intervention to manage skin problems:Find:Pt:^Patient:Ord:MDS


name: Application of dressings (with or without topical medications) other than to feet:Find:Pt:^Patient:Ord:MDS


name: Application of ointments or medications other than to feet:Find:Pt:^Patient:Ord:MDS


name: Other preventative or protective skin care other than to feet:Find:Pt:^Patient:Ord:MDS


name: Skin treatments - none of above:Find:Pt:^Patient:Ord:MDS


name: One or more foot problems:Find:Pt:^Patient:Ord:MDS


name: Open lesions on the foot:Find:Pt:^Patient:Ord:MDS


name: Nails &or calluses trimmed during last 90D:Find:90D:^Patient:Ord:MDS


name: Received preventative or protective foot care:Find:Pt:^Patient:Ord:MDS


name: Application of dressings (foot) - with or without topical medications:Find:Pt:^Patient:Ord:MDS


name: Foot problems and care - none of above:Find:Pt:^Patient:Ord:MDS


name: Activity preferences - crafts or arts:Find:Pt:^Patient:Ord:MDS


name: Activity preferences - exercise or sports:Find:Pt:^Patient:Ord:MDS


name: Activity preferences - music:Find:Pt:^Patient:Ord:MDS


name: Activity preferences - reading or writing:Find:Pt:^Patient:Ord:MDS


name: Activity preferences - spiritual or religious activities:Find:Pt:^Patient:Ord:MDS


name: Activity preferences - trips or shopping:Find:Pt:^Patient:Ord:MDS


name: Activity preferences - walking or wheeling outdoors:Find:Pt:^Patient:Ord:MDS


name: Activity preferences - watching TV:Find:Pt:^Patient:Ord:MDS


name: Activity preferences - gardening or plants:Find:Pt:^Patient:Ord:MDS


name: Activity preferences - talking or conversing:Find:Pt:^Patient:Ord:MDS


name: Activity preferences - helping others:Find:Pt:^Patient:Ord:MDS


name: Activity preferences - none of above:Find:Pt:^Patient:Ord:MDS


name: Type of activities in which resident is currently involved:Find:Pt:^Patient:Ord:MDS


name: Extent of resident involvement in activities:Find:Pt:^Patient:Ord:MDS


name: Number of D injections received:Num:Pt:^Patient:Qn:MDS


name: Number of D antipsychotic medication received:Num:Pt:^Patient:Qn:MDS


name: Number of D antianxiety medication received:Num:Pt:^Patient:Qn:MDS


name: Number of D antidepressant medication received:Num:Pt:^Patient:Qn:MDS


name: Number of D diuretic medication received:Num:Pt:^Patient:Qn:MDS


name: Monitoring of acute medical condition:Find:Pt:^Patient:Ord:MDS


name: Special behavior symptom evaluation program:Find:Pt:^Patient:Ord:MDS


name: Evaluation by a licensed mental health specialist in last 90D:Find:90D:^Patient:Ord:MDS


name: Resident-specific deliberate changes in the environment to address mood &or behavior patterns:Find:Pt:^Patient:Ord:MDS


name: Mood, behavior, cognitive loss programs - none of above:Find:Pt:^Patient:Ord:MDS


name: Number of D of passive range of motion:Num:Pt:^Patient:Qn:MDS


name: Number of D of active range of motion:Num:Pt:^Patient:Qn:MDS


name: Number of D of splint or brace assistance:Num:Pt:^Patient:Qn:MDS


name: Number of D of training & skill practice in bed mobility:Num:Pt:^Patient:Qn:MDS


name: Number of D of training & skill practice in transfer:Num:Pt:^Patient:Qn:MDS


name: Number of D of training & skill practice in walking:Num:Pt:^Patient:Qn:MDS


name: Number of D of training & skill practice in dressing or grooming:Num:Pt:^Patient:Qn:MDS


name: Number of D of training & skill practice in eating or swallowing:Num:Pt:^Patient:Qn:MDS


name: Number of D of training & skill practice in amputation or prosthesis care:Num:Pt:^Patient:Qn:MDS


name: Number of D of training & skill practice in communication:Num:Pt:^Patient:Qn:MDS


name: Number of D of other rehabilitation or restorative techniques or procedures:Num:Pt:^Patient:Qn:MDS


name: Bed rails - full bed rails on all open sides of bed:Find:Pt:^Patient:Ord:MDS


name: Number hospital admissions in last 90D:Num:90D:^Patient:Qn:MDS


name: Number of emergency room visits in last 90D:NRat:90D:^Patient:Qn:MDS


name: Number of physician visits in last 14D:NRat:14D:^Patient:Qn:MDS


name: Number of D physician orders changed in last 14D:Num:14D:^Patient:Qn:MDS


name: Abnormal lab values in last 90D:Find:90D:^Patient:Ord:MDS


name: Resident expresses &or indicates preference to return to the community:Find:Pt:^Patient:Ord:MDS


name: Resident has a support person who is positive towards discharge:Find:Pt:^Patient:Ord:MDS


name: Stay projected to be of a short duration - discharge projected within 90D:Find:90D:^Patient:Nar:MDS


name: Overall change in care needs:Find:Pt:^Patient:Ord:MDS


name: Number of D recreation therapy administered for greater than 15M:Num:Pt:^Patient:Qn:MDS


name: Total recreation therapy in last 7D:Time:7D:^Patient:Qn:MDS


name: Through D 15, provide an estimate of the number of D when at least 1 therapy service can be expected to have been delivered:Num:Pt:^Patient:Qn:MDS


name: Through day 15, provide an estimate of the number of therapy minutes (across the therapies) that can be expected to be delivered:Time:Pt:^Patient:Qn:MDS


name: Furthest distance walked without sitting down during this episode:Find:Pt:^Patient:Ord:MDS


name: Time walked without sitting down during this episode:Find:Pt:^Patient:Ord:MDS


name: Self-Performance in walking during this episode:Find:Pt:^Patient:Ord:MDS


name: Parallel bars used by resident in association with this episode:Find:Pt:^Patient:Ord:MDS


name: Cognitive loss or dementia trigger:Find:Pt:^Patient:Nar:MDS


name: Urinary incontinence and indwelling catherter trigger:Find:Pt:^Patient:Nar:MDS


name: Psychosocial well being trigger:Find:Pt:^Patient:Nar:MDS


name: Dehydration &or fluid maintenance trigger:Find:Pt:^Patient:Nar:MDS


name: Psychotropic drug use trigger:Find:Pt:^Patient:Nar:MDS


name: Resident assessment protocol 1--Delirium - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 1--Delirium - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 2--Cognitive loss - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 2--Cognitive loss - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 3--Visual function - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 3--Visual function - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 4--Communication - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 4--Communication - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 5--ADL functional &or rehab - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 5--ADL functional &or rehab - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 6--Urinary incontinence - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 6--Urinary incontinence - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 7--Psychosocial - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 7--Psychosocial - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 8--Mood state - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 8--Mood state - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 9--Behavioral symptoms - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 9--Behavioral symptoms - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 10--Activities - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 10--Activities - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 11--Falls - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 11--Falls - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 12--Nutritional status - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 12--Nutritional status - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 13--Feeding tubes - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 13--Feeding tubes - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 14--Dehydration &or Fluid maint - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 14--Dehydration &or Fluid maint - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 15--Dental care - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 15--Dental care - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 16--Pressure injuries - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 16--Pressure injuries - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 17--Psychotropic drug - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 17--Psychotropic drug - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Resident assessment protocol 18--Physical restraints - triggered:Find:Pt:^Patient:Nom:MDS


name: Resident assessment protocol 18--Physical restraints - proceed with care:Find:Pt:^Patient:Ord:MDS


name: Pneumococcal vaccine status up to date:Find:Pt:^Patient:Ord:MDS


name: Reason pneumococcal vaccine not received:Find:Pt:^Patient:Nom:CMS Assessment


name: Participation in assessment:Find:Pt:^Significant other:Ord:MDS


name: Other current or more detailed diagnoses & ICD9 codes^^^2:Prid:Pt:^Patient:Nom:MDS


name: Other current or more detailed diagnoses & ICD9 codes^^^3:Prid:Pt:^Patient:Nom:MDS


name: Other current or more detailed diagnoses & ICD9 codes^^^5:Prid:Pt:^Patient:Nom:MDS


name: Minimum data set for nursing home resident assessment and care screen:-:Pt:^Patient:-


name: Deprecated MDS basic assessment tracking form - version 2.0


name: Reasons for assessment (basic):-:Pt:^Patient:Set


name: Deprecated MDS background information at admission form - version 2.0


name: Residential history 5Y prior to entry:-:Pt:^Patient:Set


name: Conditions related to mental retardation and developmental disabilities status:-:Pt:^Patient:Set


name: Mental retardation and developmental disabilities with organic condition:-:Pt:^Patient:Set


name: Customary routine in year prior to date of entry:-:Pt:^Patient:Set


name: Identification and background information section:-:Pt:^Patient:-


name: Current payment sources for nursing home stay:-:Pt:^Patient:Set


name: Responsibility &or legal guardian:-:Pt:^Patient:Set


name: Memory recall &or ability:-:Pt:^Patient:Set


name: Indicators of delirium - periodic disorded thinking or awareness:-:Pt:^Patient:Set


name: Communication and hearing patterns section:-:Pt:^Patient:-


name: Communication devices and techniques:-:Pt:^Patient:Set


name: Visual limitations and dificulties:-:Pt:^Patient:Set


name: Mood and behavior patterns section:-:Pt:^Patient:-


name: Indicators of depression, anxiety, sad mood:-:Pt:^Patient:Set


name: Verbal expressions of distress:-:Pt:^Patient:Set


name: Sad, apethetic, anxious appearance:-:Pt:^Patient:Set


name: Psychosocial well being section:-:Pt:^Patient:-


name: Sense of initiative &or involvement:-:Pt:^Patient:Set


name: Physical functioning and stuctural problems section:-:Pt:^Patient:Set


name: ADL self performance or support:-:Pt:^Patient:Set


name: Functional limitation in range of motion:-:Pt:^Patient:Set


name: ADL functional rehabilitation potential:-:Pt:^Patient:Set


name: Continence in last 14D section:-:Pt:^Patient:Set


name: Continence appliances and programs:-:Pt:^Patient:Set


name: Endocrine, metabolic or nutritional diseases or conditions:-:Pt:^Patient:Set


name: Heart or circulation diseases or conditions:-:Pt:^Patient:Set


name: Musculoskeletal diseases or conditions:-:Pt:^Patient:Set


name: Psychiatric or mood diseases or conditions:-:Pt:^Patient:Set


name: Pulmonary diseases or conditions:-:Pt:^Patient:Set


name: Sensory diseases or conditions:-:Pt:^Patient:Set


name: Other diseases or conditions:-:Pt:^Patient:Set


name: Other current or more detailed diagnoses & ICD9 codes:-:Pt:^Patient:Set


name: Indicators of fluid status:-:Pt:^Patient:Set


name: Oral and nutritional status section:-:Pt:^Patient:-


name: Parenteral or enteral intake:-:Pt:^Patient:Set


name: Oral or dental status section:-:Pt:^Patient:-


name: Oral status and disease prevention:-:Pt:^Patient:Set


name: Type of pressure injury:-:Pt:^Patient:Set


name: Other skin problems or lesions present:-:Pt:^Patient:Set


name: Foot problems and care:-:Pt:^Patient:Set


name: Activity pursuit patterns section:-:Pt:^Patient:-


name: Prefers change in daily routine:-:Pt:^Patient:Set


name: Days received the following medication:-:Pt:^Patient:Set


name: Special treatments, procedures and programs:-:Pt:^Patient:Set


name: Intervention programs for mood, behavior and cognitive loss:-:Pt:^Patient:Set


name: Nursing rehabilitation and restorative care:-:Pt:^Patient:Set


name: Discharge potential and overall status section:-:Pt:^Patient:-


name: Therapy supplement for Medicare PPS section:-:Pt:^Patient:-


name: Special treatments and procedures:-:Pt:^Patient:Set


name: Walking when most self sufficient:-:Pt:^Patient:Set


name: Deprecated Minimum Data Set (MDS) supplemental items section - version 2.0


name: Pregnenolone^1H post 250 ug corticotropin:MCnc:Pt:Ser/Plas:Qn


name: Deprecated MDS quarterly assessment form - version 2.0 - optional version for RUG-III


name: Deprecated MDS quarterly assessment form - version 2.0 - optional version for RUG-III 1997 update


name: Deprecated Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma by Nephlometry


name: Clostridioides difficile toxin B:PrThr:Pt:Stool:Ord:Cytotoxin tissue culture assay


name: Triple phosphate crystals:Naric:Pt:Urine sed:Qn:Microscopy.light.HPF


name: Other current diagnoses & ICD9 codes (quarterly):-:Pt:^Patient:Set


name: Continence appliances and programs (quarterly):-:Pt:^Patient:Set


name: Modes of transfer (quarterly):-:Pt:^Patient:Set


name: ADL self performance or support (quarterly):-:Pt:^Patient:Set


name: Nutritional approaches (quarterly RUG-III):-:Pt:^Patient:Set


name: Problem conditions (quarterly RUG-III):-:Pt:^Patient:Set


name: Bowel elimination pattern (quarterly RUG-III):-:Pt:^Patient:Set


name: Diseases (quarterly RUG-III 97 update):-:Pt:^Patient:Set


name: Oral problems (quarterly RUG-II):-:Pt:^Patient:Set


name: Ascaris lumbricoides larva Ab.IgG:ACnc:Pt:Ser:Qn


name: Cache valley virus Ab:Titr:Pt:Ser:SemiQn


name: Chlamydia trachomatis D+E+F+G+H+I+J+K Ab.IgA:Titr:Pt:Ser:SemiQn


name: Classical swine fever virus Ab:Titr:Pt:Ser:SemiQn


name: Equine herpesvirus 1 Ab:Titr:Pt:CSF:SemiQn


name: Equine herpesvirus 2 Ab:Titr:Pt:Ser:SemiQn


name: Equine herpesvirus 3 Ab:Titr:Pt:Ser:SemiQn


name: Herpes simplex virus Ab:PrThr:Pt:Body fld:Ord


name: Infectious bronchitis virus JMK Ab:Titr:Pt:Ser:SemiQn


name: Legionella non pneumophila sp Ab:Titr:Pt:Ser:SemiQn


name: Salmonella typhi O D Ab:Titr:Pt:Ser:SemiQn


name: Tilt table study:Find:Pt:Cardiovascular system:Doc


name: Views^during surgery W contrast retrograde:Find:Pt:Abdomen>Kidney:Doc:XR


name: Chlamydia trachomatis L2 Ab.IgA:Titr:Pt:Ser:SemiQn:IF


name: Myelin associated glycoprotein-sulfated glucuronic paragloboside Ab.IgM:Titr:Pt:Ser:SemiQn:IA


name: Cortisol^15M post dose corticotropin IM:MCnc:Pt:Ser/Plas:Qn


name: Saint Louis encephalitis virus Ab.IgG:PrThr:Pt:Ser:Ord


name: Leishmania chagasi K39 Ab:PrThr:Pt:Ser:Ord


name: Avian metapneumovirus A Ab:Titr:Pt:Ser:SemiQn:IA


name: Avian metapneumovirus B Ab:PrThr:Pt:Ser:Ord:IF


name: Equine herpesvirus 2 Ab.Neut:Titr:Pt:Ser:SemiQn:Neut


name: Infectious bronchitis virus JMK Ab:Titr:Pt:Ser:SemiQn:HAI


name: Avian metapneumovirus C Ab:PrThr:Pt:Ser:Ord


name: Figure associated with report or note:-:Pt:^Patient:-


name: Streptococcus sp identified:Prid:Pt:Isolate:Nom:Organism specific culture


name: Erythrocyte sedimentation rate:Vel:Pt:Bld:Qn:15M reading


name: Stem cell product given:Vol:Pt:^Patient:Qn


name: Bartonella henselae & Bartonella quintana Ab.IgM panel:-:Pt:CSF:-


name: Guidance for percutaneous drainage of abscess+placement of drainage catheter:Find:Pt:XXX:Doc:CT


name: Views^during electroconvulsive shock treatment:Find:Pt:Head>Brain:Doc:NM


name: Views runoff^W contrast IA:Find:Pt:Abdomen>Aorta.abdominal:Doc:RF.angio


name: Chlamydia trachomatis D+K Ab.IgG:PrThr:Pt:Ser:Ord


name: Multisection^WO contrast:Find:Pt:Lower extremity.right>Thigh vessels:Doc:MR.angio


name: Guidance for drainage+placement of drainage catheter:Find:Pt:XXX:Doc:RF


name: Views for bone density:Find:Pt:Whole body>Skeletal system.axial:Doc:NM


name: Guidance for deep biopsy:Find:Pt:XXX>Bone:Doc:US


name: Albumin:MRat:12H:Urine:Qn:Detection limit <= 20 mg/L


name: Views for blood flow^W Tc-99m DTPA IV:Find:Pt:Head>Brain:Doc:NM


name: Views quantitative for infarct^W radionuclide IV:Find:Pt:Chest>Heart:Doc:NM


name: Views perfusion quantitative^W radionuclide IV:Find:Pt:Chest>Lung:Doc:NM


name: Herpes simplex virus identified:Prid:Pt:CSF:Nom:Shell vial culture


name: SURF1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Views perfusion^at rest+W adenosine+W Tl-201 IV:Find:Pt:Chest>Heart:Doc:NM


name: Influenza virus A Ab.IgG:PrThr:Pt:Ser:Ord


name: Influenza virus B Ab.IgG:PrThr:Pt:Ser:Ord


name: Clarithromycin 3.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Aspergillus flavus B Ab:PrThr:Pt:Ser:Ord:Immune diffusion


name: Aspergillus fumigatus B Ab:PrThr:Pt:Ser:Ord:Immune diffusion


name: Aspergillus nidulans H Ab:PrThr:Pt:Ser:Ord:Immune diffusion


name: Chlamydia trachomatis Ab.IgA & IgG & IgM:Imp:Pt:Ser:Nom


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Retroperitoneum:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Abdomen>Adrenal gland:Doc:MR


name: Views^W Tc-99m medronate IV:Find:Pt:XXX>Bone:Doc:NM


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Retroperitoneum:Doc:US


name: Views GE 3:Find:Pt:Lower extremity>Foot:Doc:XR


name: Views GE 4^W R-Bending + W L-Bending:Find:Pt:XXX>Spine:Doc:XR


name: View for scoliosis:Find:Pt:Chest>Spine.thoracic & Abdomen>Spine.lumbar:Doc:XR


name: Guidance for percutaneous aspiration.fine needle:Find:Pt:Neck>Thyroid gland:Doc:RF


name: Multisection^WO & W contrast IV:Find:Pt:Abdomen>Superior mesenteric vessels:Doc:MR.angio


name: Multisection limited for graft:Find:Pt:Upper extremity.bilateral>Upper extremity vessel:Doc:US.doppler


name: Influenza virus A H6 RNA:ACnc:Pt:XXX:Qn:Probe.amp.tar


name: Immune complex:PrThr:Pt:Ser/Plas:Ord:Raji cell assay


name: Beta 2 glycoprotein 1 Ab.IgG:ACnc:Pt:Ser/Plas:Qn:IA


name: Borrelia burgdorferi Ab^1st specimen:ACnc:Pt:Ser:Qn:IA


name: Herpes simplex virus 1:PrThr:Pt:Vag:Ord:Organism specific culture


name: Herpes simplex virus 1 Ab:PrThr:Pt:Body fld:Ord


name: Herpes simplex virus 2:PrThr:Pt:Genital:Ord:Organism specific culture


name: Herpes simplex virus Ag:PrThr:Pt:Cvx:Ord:IF


name: Herpes virus 6 Ab.IgG:PrThr:Pt:Ser:Ord:IF


name: Margin involvement:Find:Pt:Prostate tumor:Nom:CAP cancer protocols


name: Invasive carcinoma.uninvolved margin distance.closest:Len:Pt:Breast tumor:Qn


name: Lymphocyte proliferation. 0.50 ug pokeweed mitogen stimulation:NRat:Pt:Bld:Qn


name: Periprostatic fat invasion:Prid:Pt:Specimen:Nom:CAP cancer protocols


name: Dominant nodule.additional dimension 2:Len:Pt:Prostate tumor:Qn


name: Margin(s) involved by invasive carcinoma:Find:Pt:Prostate tumor:Nom


name: Liver transplant anastomosis site:Anat:Pt:Hepatic artery:Nom


name: Liver transplant anastomosis site:Anat:Pt:Hepatic artery^Graft:Nom


name: Burkholderia sp:PrThr:Pt:XXX:Ord:Organism specific culture


name: GNE gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: La Crosse virus Ab.IgM:Titr:Pt:Ser:SemiQn:IA


name: Insulin dependent diabetes mellitus:PrThr:Pt:^Patient:Ord


name: Prolactin^1H post dose TRH IV:ACnc:Pt:Ser/Plas:Qn


name: Prolactin^15M post dose TRH IV:ACnc:Pt:Ser/Plas:Qn


name: Borrelia burgdorferi 31kD Ab.IgM:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 34kD Ab.IgM:PrThr:Pt:Ser:Ord:IB


name: Adenosine monophosphate.cyclic/Creatinine^4H post XXX challenge:Ratio:Pt:Urine:Qn


name: Preferred activity setting - day or activity room:Find:Pt:^Patient:Ord:MDS


name: Ehrlichia chaffeensis Ab.IgG & IgM panel:Titr:XXX:Ser:SemiQn:IF


name: Protein & Glucose panel:-:Pt:Urine:-:Test strip


name: Chlamydia trachomatis+Neisseria gonorrhoeae rRNA:PrThr:Pt:Cvx:Ord:Probe


name: Cocal virus Ag:PrThr:Pt:XXX:Ord:Comp fix


name: Sjogrens syndrome-B extractable nuclear Ab:ACnc:Pt:Ser:Qn:IA


name: CASR gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Isoniazid 2.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Choriogonadotropin.beta subunit.free multiple of the median:Prctl:Pt:Ser/Plas:SemiQn


name: Date Rh immune globulin given:Date:Pt:^Patient:Qn


name: Lymphocyte proliferation. 2.0 ug phytohemagglutinin stimulation:NRat:Pt:Bld:Qn


name: Lymphocyte proliferation. 5 ug concanavalin A stimulation:NRat:Pt:Bld:Qn


name: Date of transfusion reaction:TmStp:Pt:^Patient:Qn


name: Medicare or comparable number:ID:Pt:^Patient:Nom


name: Change in communication &or hearing:Find:Pt:^Patient:Ord:MDS


name: History of prior stay at this nursing home:Find:Pt:^Patient:Ord:MDS


name: History of stay in mental retardation and developmental disabilities setting:Find:Pt:^Patient:Ord:MDS


name: Spends most time alone or watching TV:Find:Pt:^Patient:Ord:MDS


name: Wakens to toilet all or most nights:Find:Pt:^Patient:Ord:MDS


name: Self or family pays for full per diem:Find:Pt:^Patient:Ord:MDS


name: Uses other modes of expression:Find:Pt:^Patient:Ord:MDS


name: No mode of transfer:Find:Pt:^Patient:Ord:MDS


name: Alterability of physically abusive behavioral symptoms:Find:Pt:^Patient:Ord:MDS


name: Strong identification with past roles and life status:Find:Pt:^Patient:Ord:MDS


name: Resident perceives that daily routine (customary routine, activities) is very different from prior pattern in the community:Find:Pt:^Patient:Ord:MDS


name: Locomotion off unit - support provided during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Change in urinary continence:Find:Pt:^Patient:Ord:MDS


name: Infections - none of above:Find:Pt:^Patient:Ord:MDS


name: Chest pain while doing usual activities:Find:Pt:^Patient:Ord:MDS


name: Number of D with at least 15M of speech language pathology and audiology services in the last 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Stasis pressure injury stage:Find:Pt:^Patient:Nom:MDS


name: History of resolved ulcers:Find:Pt:^Patient:Ord:MDS


name: Activity preferences - cards or other games:Find:Pt:^Patient:Ord:MDS


name: Number of D hypnotic medication received:Num:Pt:^Patient:Qn:MDS


name: Total minutes of psychological therapy by any licensed mental health professional in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Bed rails - other types of side rails used:Find:Pt:^Patient:Ord:MDS


name: Therapy orders to begin in 1st 14D of stay:Find:Pt:^Patient:Ord:MDS


name: Other current or more detailed diagnoses & ICD9 codes^^^4:Prid:Pt:^Patient:Nom:MDS


name: Deprecated MDS full assessment form - version 2.0


name: Disease or condition diagnoses section:-:Pt:^Patient:-


name: Neurological diseases or conditions:-:Pt:^Patient:Set


name: Special treatments and procedures section:-:Pt:^Patient:-


name: Deprecated MDS quarterly assessment form - version 2.0


name: Bowel elimination pattern (quarterly):-:Pt:^Patient:Set


name: Ascaris lumbricoides adult Ab.IgG:ACnc:Pt:Ser:Qn


name: Chlamydia trachomatis D+E+F+G+H+I+J+K Ab.IgG:Titr:Pt:Ser:SemiQn


name: Chlamydia trachomatis D+E+F+G+H+I+J+K Ab.IgM:Titr:Pt:Ser:SemiQn


name: 15 Beta, 17 Alpha-Dihydroxypregnanolone/Creatinine


name: ADL self performance or support (quarterly)


name: Advance directive - feeding restrictions


name: Alzheimer's or dementia special care unit


name: Archive facility identification number NPI


name: Bartonella henselae & Bartonella quintana Ab.IgG & IgM panel


name: Bartonella henselae & Bartonella quintana Ab.IgM panel


name: Basic metabolic panel & Glomerular filtration rate.predicted


name: Beta 2 globulin+Gamma globulin/Protein.total


name: Communication and hearing patterns section


name: Continence appliances and programs (quarterly)


name: Creatinine & Glomerular filtration rate.predicted panel


name: cycloSPORINE.monoclonal & polyclonal panel


name: Date background information form completed


name: Dehydration &or fluid maintenance trigger


name: Depth of invasion by tumor cannot be determined comment


name: Discharge potential and overall status section


name: Distance of invasive melanoma to closest deep margin


name: Distance of melanoma in situ to closest lateral margin


name: Dolichovespula maculata Ab.IgG.RAST class


name: Ehrlichia chaffeensis Ab.IgG & IgM panel


name: Fatty acid panel.very long chain C22-C26


name: Glycogen synthase I/Glycogen synthase.total


name: Guidance for change of dialysis catheter


name: Guidance for localization of bleeding site


name: Guidance for needle localization of mass


name: Histoplasma capsulatum H Ab band pattern


name: Histoplasma capsulatum M Ab band pattern


name: Horse hair+Horse dander Ab.IgE.RAST class


name: House dust Hollister Stier Ab.IgG.RAST class


name: Human prescription drug label with highlights


name: Identification and background information section


name: Intervention programs for mood, behavior and cognitive loss


name: Invasive carcinoma.uninvolved margin distance.closest


name: Invasive component size.additional dimension 2


name: Lymphocyte proliferation. 0.125 ug pokeweed mitogen stimulation


name: Lymphocyte proliferation. 0.25 ug pokeweed mitogen stimulation


name: Lymphocyte proliferation. 0.50 ug pokeweed mitogen stimulation


name: Lymphocyte proliferation. 1.0 ug pokeweed mitogen stimulation


name: Lymphocyte proliferation. 10 ug concanavalin A stimulation


name: Lymphocyte proliferation. 2.0 ug phytohemagglutinin stimulation


name: Lymphocyte proliferation. 20 ug concanavalin A stimulation


name: Melanoma in situ.location relative to closest uninvolved lateral margin


name: Melanoma in situ.location relative to involved lateral margin


name: Number of D recreation therapy administered for greater than 15M


name: Number of D antianxiety medication received


name: Number of D diuretic medication received


name: Number of D hypnotic medication received


name: Number of D physician orders changed in last 14D


name: Nutritional approaches (quarterly RUG-III)


name: Parietaria officinalis Ab.IgE.RAST class


name: Physical functioning and stuctural problems section


name: Rat epithelium+Serum proteins+Urine proteins Ab.IgE.RAST class


name: Regional lymph nodes containing metastases


name: Resident assessment protocol 1--Delirium - proceed with care


name: Resident assessment protocol 1--Delirium - triggered


name: Resident assessment protocol 10--Activities - proceed with care


name: Resident assessment protocol 11--Falls - proceed with care


name: Resident assessment protocol 11--Falls - triggered


name: Resident assessment protocol 12--Nutritional status - triggered


name: Resident assessment protocol 13--Feeding tubes - proceed with care


name: Resident assessment protocol 13--Feeding tubes - triggered


name: Resident assessment protocol 14--Dehydration &or Fluid maint - proceed with care


name: Resident assessment protocol 14--Dehydration &or Fluid maint - triggered


name: Resident assessment protocol 15--Dental care - proceed with care


name: Resident assessment protocol 15--Dental care - triggered


name: Resident assessment protocol 17--Psychotropic drug - proceed with care


name: Resident assessment protocol 18--Physical restraints - proceed with care


name: Resident assessment protocol 18--Physical restraints - triggered


name: Resident assessment protocol 2--Cognitive loss - proceed with care


name: Resident assessment protocol 2--Cognitive loss - triggered


name: Resident assessment protocol 3--Visual function - proceed with care


name: Resident assessment protocol 3--Visual function - triggered


name: Resident assessment protocol 4--Communication - triggered


name: Resident assessment protocol 5--ADL functional &or rehab - proceed with care


name: Resident assessment protocol 5--ADL functional &or rehab - triggered


name: Resident assessment protocol 6--Urinary incontinence - proceed with care


name: Resident assessment protocol 6--Urinary incontinence - triggered


name: Resident assessment protocol 7--Psychosocial - proceed with care


name: Resident assessment protocol 7--Psychosocial - triggered


name: Resident assessment protocol 8--Mood state - proceed with care


name: Resident assessment protocol 8--Mood state - triggered


name: Resident assessment protocol 9--Behavioral symptoms - proceed with care


name: Resident assessment protocol 9--Behavioral symptoms - triggered


name: Resident assessment protocol summary section


name: Special treatments and procedures section


name: Special treatments, procedures and programs


name: Triglycerides to HDL Cholesterol Ratio Measurement


name: Views AP (KUB & upright) & upright chest


name: Views AP (supine KUB & upright) & PA upright chest


name: Views for endocrine tumor multiple areas


name: Bartonella henselae & Bartonella quintana Ab.IgG panel


name: W gastrografin PO and W barium contrast PR


name: Comprehensive metabolic panel & Glomerular filtration rate.predicted


name: Assessment using PHQ-9 depression questionnaire


name: Views qualitative+quantitative for infarct


name: Therapy supplement for Medicare PPS section


name: Resident assessment protocol 17--Psychotropic drug - triggered


name: Resident assessment protocol 12--Nutritional status - proceed with care


name: Invasive component size.additional dimension 1


name: Advance directive - other treatment restrictions:Find:Pt:^Patient:Ord:MDS


name: Alkaline phosphatase.heat stable/Alkaline phosphatase.total


name: CIAS1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Number of D antipsychotic medication received


name: Nursing rehabilitation and restorative care


name: Resident assessment protocol 10--Activities - triggered


name: Resident assessment protocol 4--Communication - proceed with care


name: Distance of invasive melanoma to closest lateral margin


name: Insertion or replacement of implantable pressure sensor with lead for intracardiac or great vessel hemodynamic monitoring


name: Implantation or replacement of subcutaneous device for intracardiac or great vessel hemodynamic monitoring


name: Implantation of monitoring device with formation of subcutaneous pocket and connection to intracardiac pressure sensor (lead)


name: Resurfacing hip, total, acetabulum and femoral head


name: Hip resurfacing arthroplasty, partial, femoral head


name: Removal of catheter(s) from cranial cavity or tissue


name: Placement of intracerebral catheter(s) via burr hole(s)


name: Convection enhanced delivery of intracerebral catheter(s)


name: Stereotactic placement of intracerebral catheter(s)


name: Operation on lens, not elsewhere classified


name: Implantation of intraocular telescope prosthesis


name: Percutaneous ablation of lung lesion or tissue


name: Thoracoscopic ablation of lung lesion or tissue


name: Other and unspecified ablation of lung lesion or tissue


name: Endoscopic insertion or replacement of bronchial valve(s), single lobe


name: Intrabronchial airflow redirection valve


name: Endoscopic removal of bronchial device(s) or substances


name: Endoscopic insertion of other bronchial device or substances


name: Biologic Lung Volume Reduction NOS (BLVR)


name: Repair of ventricular septal defect with prosthesis, closed technique


name: Noninvasive programmed electrical stimulation [NIPS]


name: Repositioning of (cardiac device) lead(s)


name: Repositioning of (defibrillator) lead(s)


name: Removal of cardiac device/pulse generator without replacement


name: Removal of implantable hemodynamic pressure sensor (lead) and monitor device


name: Removal without replacement of cardiac resynchronization defibrillator device


name: Repositioning of implantable hemodynamic pressure sensor (lead) and monitor device


name: Revision of cardioverter/defibrillator (automatic) pocket


name: Revision of pocket for intracardiac hemodynamic monitoring


name: Implantation of defibrillator with epicardial patches, formation of abdominal fascia pocket, any transvenous leads, intraoperative procedures for evaluation of lead signals and obtaining defibrillator threshold measurements


name: Implantation of defibrillator with epicardial patches, formation of pocket, any transvenous leads, intraoperative procedures for evaluation of lead signals and obtaining defibrillator threshold measurements


name: Implantation of defibrillator with epicardial patches, formation of subcutaneous pocket, any transvenous leads, intraoperative procedures for evaluation of lead signals and obtaining defibrillator threshold measurements


name: Implantation of defibrillator with leads (epicardial patches), formation of pocket (abdominal fascia) (subcutaneous), any transvenous leads, intraoperative procedures for evaluation of lead signals, and obtaining defibrillator threshold measurements


name: Implantation of defibrillator with leads, formation of abdominal fascia pocket, any transvenous leads, intraoperative procedures for evaluation of lead signals and obtaining defibrillator threshold measurements


name: Implantation of defibrillator with leads, formation of pocket, any transvenous leads, intraoperative procedures for evaluation of lead signals and obtaining defibrillator threshold measurements


name: Implantation of defibrillator with leads, formation of subcutaneous pocket, any transvenous leads, intraoperative procedures for evaluation of lead signals and obtaining defibrillator threshold measurements


name: Implantation or replacement of the total automatic cardioverter/defibrillator system by lateral thoracotomy techniques


name: Implantation or replacement of the total automatic cardioverter/defibrillator system by medial sternotomy techniques


name: Implantation or replacement of the total automatic cardioverter/defibrillator system by subxiphoid procedure techniques


name: Partial resection of vessel with replacement


name: Endovascular thrombectomy of pre-cerebral and cerebral vessels


name: Percutaneous ablation of liver lesion or tissue


name: Laparoscopic ablation of liver lesion or tissue


name: Other and unspecified ablation of liver lesion or tissue


name: Percutaneous ablation of renal lesion or tissue


name: Laparoscopic ablation of renal lesion or tissue


name: Other and unspecified ablation of renal lesion or tissue


name: Fetal reduction of multiple fetuses reduced to single fetus


name: Other and unspecified subtotal abdominal hysterectomy


name: laparoscopic total abdominal hysterectomy


name: Other and unspecified vaginal hysterectomy


name: Laparoscopic radical abdominal hysterectomy


name: Laparoscopic modified radical hysterectomy


name: Total laparoscopic radical hysterectomy [TLRH]


name: Other and unspecified radical abdominal hysterectomy


name: Other and unspecified radical vaginal hysterectomy


name: Vaginal hysterectomy, radical (Schauta type operation)


name: Computer (assisted) (dependent) external fixator device


name: Testing of female for genetic disease carrier status


name: Testing of male for genetic disease carrier status


name: PERSONS WITHOUT REPORTED DIAGNOSIS ENCOUNTERED DURING EXAMINATION AND INVESTIGATION OF INDIVIDUALS AND POPULATIONS


name: screening for genetic disease carrier status


name: Other and unspecified total abdominal hysterectomy


name: Insertion of catheter(s) into cranial cavity or tissue


name: Endovascular removal of obstruction from head and neck vessel(s)


name: Hip resurfacing arthroplasty, partial, acetabulum


name: Laparoscopic radical vaginal hysterectomy [LRVH]


name: Phacoemulsification machine, Venturi pump


name: Central nervous system stage B2 in retinoblastoma


name: Lyophilized powder for suspension for injection


name: Choroidal invasion stage C1 in retinoblastoma


name: magnesium carbonate / sodium bicarbonate


name: Fine needle biopsy of gastrointestinal tract


name: Descemet Stripping Endothelial Keratoplasty


name: A4beta2 acetylcholine receptor partial agonist (product)


name: Aluminum hydroxide- and simethicone-containing product


name: Four times daily after meals and at bedtime


name: Timing of liver tumor staging pre-surgery


name: Characteristic of jugular venous distention


name: magnesium hydroxide / omeprazole / sodium bicarbonate


name: Provider medication administration instructions


name: Lyophilized Powder for Injectable Liposomal Suspension Dosage Form


name: Four times daily before meals and at bedtime


name: Measurement of Saccharopolyspora rectivirgula antibody


name: Presbyopia - correcting intraocular len implant


name: Timing of liver tumor staging at diagnosis


name: West Nile virus IgG antibody measurement


name: Choroidal invasion stage C3 in retinoblastoma


name: Raster photogrammetry corneal topography


name: Central nervous system stage B1 in retinoblastoma


name: Calculation of corneal tissue ablation depth


name: Injectable Liposomal Suspension Dosage Form


name: choline salicylate, glycerol drug combination


name: Choroidal invasion stage C0 in retinoblastoma


name: activated charcoal / magnesium hydroxide


name: Powder for prolonged-release suspension for injection


name: Prolonged-release suspension for injection


name: West Nile virus IgM antibody measurement


name: Saccharopolyspora rectivirgula specific IgG antibody measurement


name: Phacoemulsification machine, peristaltic pump


name: Specimen from appendix obtained by appendectomy


name: Lyophilized powder for solution for injection


name: Optic nerve invasion stage N1 in retinoblastoma


name: Cardiac Intraventricular Route of Administration


name: Optic nerve invasion stage N0 in retinoblastoma


name: Substance with antifilarial mechanism of action


name: Random dot stereo depth perception testing


name: Cytomegalovirus culture, conventional and rapid


name: Cholinergic receptor stimulating preparation


name: Injectable Sonicated Suspension Dosage Form


name: Central nervous system stage B3 in retinoblastoma


name: Choroidal invasion stage C4 in retinoblastoma


name: Helium only product in gas for inhalation


name: Choroidal invasion stage C2 in retinoblastoma


name: Optic nerve invasion stage N3 in retinoblastoma


name: Animal Nutritional Physiological Phenomena


name: Child Nutritional Physiological Phenomena


name: Adolescent Nutritional Physiological Phenomena


name: Maternal Nutritional Physiological Phenomena


name: Proprioceptive Neuromuscular Facilitation (PNF) Stretching


name: Magnetic Resonance Imaging, Interventional


name: osteogenic protein 1 putty, recombinant human


name: Automatic Inflate Blood Pressure/Pulse Monito


name: BD ACE Gold Sock, Black, Large, Men (obslte)


name: BD ACE Gold Sock, Black, Medium, Men (obslte)


name: Protective Underwear Extra Absorbent Extra La


name: Protective Underwear Extra Absorbent Large


name: Protective Underwear Extra Absorbent Small-Me


name: Protective Underwear Super Absorbent Extra La


name: Protective Underwear Ultra Slim Small-Medium


name: Self-Taking Manual Inflate Blood Pressure Kit


name: BD Hose T.E.D. Small-Large Hospital (obslte)


name: Deluxe Automatic Inflate Blood Pressure/Pulse


name: Deluxe Wrist Blood Pressure/Pulse Monitor


name: Manual Inflate Blood Pressure/Pulse Monitor


name: Pediatric Electrolyte Fruit, oral solution


name: Walgreens Land Before Time Diaper Jumbo 3T-4T


name: Walgreens Land Before Time Diaper Jumbo Size


name: Walgreens Land Before Time Diaper Mega Size 3


name: Walgreens Land Before Time Diaper Mega Size 4


name: Walgreens Land Before Time Diaper Mega Size 5


name: Walgreens Land Before Time Diaper Size 1


name: Walgreens Land Before Time Diaper Size 3


name: Walgreens Land Before Time Diaper Size 5


name: Walgreens Land Before Time Diaper Size 6


name: {90 (insulin human, rDNA origin 1 MG Inhalation Powder [Exubera]) / 90 (insulin human, rDNA origin 3 MG Inhalation Powder [Exubera]) } Pack [Exubera Combination Pack 12]


name: {180 (insulin human, rDNA origin 1 MG Inhalation Powder [Exubera]) / 90 (insulin human, rDNA origin 3 MG Inhalation Powder [Exubera]) } Pack [Exubera Kit]


name: Nutritional Drink Plus Walgreens Strawberry


name: Nutritional Drink Plus Walgreens Vanilla


name: syringe filter 25 millimeter-0.2 micron MISCELL EACH


name: syringe with cannula, disposable, 3 mL 17 gauge MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe with cannula, disposable, 3 mL MISCELL SYRINGE (EA)


name: syringe with cannula, disposable, 6 mL MISCELL SYRINGE (EA)


name: syringe with needle,disposable,insulin 1 mL 30 gauge X 3/8" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe with cannula,disposable 12 mL MISCELL SYRINGE (EA)


name: syringe,safety with needle,1 mL 25 gauge X 1" MISCELL SYRINGE (EA)


name: urostomy sets, sterile 2 1/4" (Barrier up to 1 3/4") (9") MISCELL EACH


name: blood-glucose meter and wrist blood pressure monitor MISCELL KIT


name: colostomy bag, non-sterile 1 3/16" (12") MISCELL EACH


name: colostomy bag, non-sterile 1 3/16" (7") MISCELL EACH


name: colostomy bag, non-sterile 1 3/16" (9") MISCELL EACH


name: colostomy bag, non-sterile 1 3/4" (7") MISCELL EACH


name: colostomy bag, non-sterile 1 3/8" (9") MISCELL EACH


name: colostomy bag, non-sterile 1 9/16" (11") MISCELL EACH


name: colostomy bag, non-sterile 1" (7") MISCELL EACH


name: colostomy bag, non-sterile 10 1/2" 485 mL MISCELL EACH


name: colostomy bag, non-sterile 11 1/4" 600 mL MISCELL EACH


name: colostomy bag, non-sterile 2 1/4" (7") MISCELL EACH


name: colostomy bag, non-sterile 2 3/4" (12") MISCELL EACH


name: colostomy bag, non-sterile 2 3/4" (7") MISCELL EACH


name: colostomy bag, non-sterile 4" (12") MISCELL EACH


name: colostomy bag, non-sterile 5/8"-2 1/8" (12") MISCELL EACH


name: colostomy bag, non-sterile 5/8"-2 1/8" (9") MISCELL EACH


name: Land Before Time Convenience Diapers 3T-4T


name: colostomy-ileostomy sets, non-sterile 2 1/4" (Barrier up to 1 3/4") (12") MISCELL EACH


name: colostomy-ileostomy sets, non-sterile 2 3/4" (Barrier up to 2 1/4") (12") MISCELL EACH


name: dressing, odor absorbent, hydropolymer 2" X 2" MISCELL BANDAGE


name: dressing, odor absorbent, hydropolymer 4" X 3.6" MISCELL BANDAGE


name: dressing, odor absorbent, hydropolymer 4" X 4" MISCELL BANDAGE


name: dressing, odor absorbent, hydropolymer 6" X 6 1/2" MISCELL BANDAGE


name: dressing, odor absorbent, hydropolymer 6" X 6" MISCELL BANDAGE


name: dressing, odor absorbent, hydropolymer 8" X 8" MISCELL BANDAGE


name: inspiratory pressure threshold loading device


name: monitoring agent for oral anticoagulation


name: oral mucositis/stomatitis anti-inflamm. agent cmb1


name: nut.therapy, phenylketonuria (PKU) with iron, no.5


name: nut.therapy, phenylketonuria (PKU) with iron, no.6


name: nut.therapy, phenylketonuria (PKU) with iron, no.7


name: nut. tx., metabolic disorder, methionine-free


name: ostomy lubricating deodorant MISCELL LIQUID (ML)


name: Efavirenz- and emtricitabine- and tenofovir-containing product


name: {21 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Sronyx 28 Day]


name: Nutritional Drink Plus Walgreens Chocolate


name: Prescision Xtra Glucose and Ketone Test Strip


name: Protective Underwear Super Absorbent Large


name: Graftskin Topical application Sheet [DERMAGRAFT]


name: {51 (dexamethasone 1.5 MG Oral Tablet) } Pack


name: Administer IV fluids rapidly (1000 mL/hr) to support blood pressure, per physician order or protocol


name: Puncture skin manually with a lancet or an approved penetration device according to manufacturer's specifications


name: Collect blood in manner appropriate to test being performed (e.g., allow a drop of blood to fall onto manufacturer's specified area of filter paper or test strips, draw blood into tubes by capillary action as droplets form)


name: Teach caregiver techniques to improve security of patient


name: Ask for clarification if the question is unclear


name: Teach patient to avoid mechanical compression of peripheral access site


name: Monitor weight 3 times weekly initially, decreasing to once a month


name: Facilitate use of personal items such as pajamas, robes, and toiletries


name: Confirm that emergency plans are in place


name: Screen populations at risk for evidence of exposure to environmental hazards


name: Assess for verbal and nonverbal signs of anxiety


name: Prescribe and/or renew asthma medications, as appropriate


name: Administer medication, as appropriate and/or per policy and procedural guidelines


name: Determine baseline respiratory status to use as a comparison point


name: Assist in the recognition of signs/symptoms of impending asthmatic reaction and implementation of appropriate response measures


name: Monitor the patient's response to the medication


name: Monitor fluid status, including intake and output


name: Position the patient in a comfortable position during the procedure


name: Update significant others on patient's status, as appropriate


name: Ensure that the patient receiving ECT has complied with the NPO requirement and medication instructions as ordered by the physician


name: Treat disorientation by restricting environmental stimulation and frequently reorienting patient


name: Monitor individual's adherence to exercise program/activity


name: Provide information about types of muscle resistance that can be used (e.g., free weights, weight machines, rubberized stretch bands, weighted objects, aquatic)


name: Identify behaviors and factors that affect risk of falls


name: Coach patient to adapt to suggested gait modifications


name: Consult with community resources for information


name: Assist patient to identify belief system that affects health status


name: Teach patient or family about normal digestive processes


name: Establish a personal relationship with the patient and family members who will be involved in care


name: Inform family of behavior expectations and limits


name: Participate in the evaluation of staff's and own emotional needs


name: Provide information on how to obtain equipment


name: Assist patient or family to coordinate health care and communication


name: Facilitate changes in hormone replacement therapy with primary care provider, as appropriate


name: Adjust medications or medication dose, as appropriate


name: Assist the patient to realize the ability to prevent illness or condition, as appropriate


name: Inspect lower extremities for presence of edema


name: Monitor joint mobility (e.g., ankle dorsiflexion and subtalar joint motion)


name: Position patient in a side-lying position with ear to be treated facing up or have patient sit in chair


name: Notify physician if epidural or intrathecal dressing is wet


name: Discuss financial concerns related to medication regimen


name: Verify that decimal points used in dosages are clearly seen by using leading zeros (e.g., 0.2 vs. .2)


name: Inform the individual as to the purpose of the music experience


name: Determine need for enteral tube feedings


name: Express confidence that patient can resume normal life with ostomy


name: Instruct the patient to report signs of infection (e.g., fever, chills, drainage from insertion site)


name: Instruct individual to avoid smoking for 1 hour and alcoholic beverages for 3 hours after donation


name: Instruct individual to increase fluid intake for 2 days after donation


name: Monitor for side effects of the treatment (e.g., headache, eyestrain, nausea, insomnia, hyperactivity)


name: Provide information about symptom specific self-care measures (e.g., exercise and calcium supplementation)


name: Assist individual in maintaining a healthy weight


name: Assign a "buddy" to the individual to help acquaint him or her to the new environment


name: Provide appropriate container for used sharps, as appropriate


name: Determine needs for home enhancements to offset disabilities (e.g., large numbers on telephones, increased volume of telephone ringer, laundry and other facilities located on main floor; side rails in hallways, grab-bars in bathrooms)


name: Determine individual's need for assistance with instrumental activities of daily living (e.g., shopping, cooking, housekeeping, laundry, use of transportation, managing money, managing medications, use of communication, and use of time)


name: Instruct assisting person in completing appropriate setting-up tasks so that individual can complete task (e.g., chop up vegetables so individual can cook with them, place clothing to wear for the day in an easy-to-reach place, unpack groceries on countertop for eventual storage)


name: Identify methods to prevent injury during transfer


name: Solicit the patient's feedback regarding his/her comfort with the procedure and experience of self-hypnosis


name: Assist the patient to process and interpret what occurs as a result of the self-hypnosis sessions


name: Keep skin donor site clean, dry, and free from pressure


name: Support patient to appropriately ventilate anger, hostility, and frustration if graft does not take


name: Reassure patient that physical withdrawal symptoms from nicotine are temporary


name: Explore strengths and weaknesses of current network of relationships


name: Ensure privacy and safety while undressing and bathing


name: Provide comfortable environmental (e.g., temperature, lighting, reduced noise)


name: Monitor for verbal and nonverbal warning signs of increasing agitation


name: Spell unusual words after clearly enunciating them, if requested


name: Answer a question only if the person asking is finished; do not interject words when a question is being asked


name: Take action to prevent individual from harming or killing self, when contract is a no-self-harm or safety contract (e.g., increased observation, removal of objects that may be used to harm self)


name: Determine adequacy of food supplies in home


name: Recommend daily foot inspection over all surfaces and between the toes, looking for redness, swelling, warmth, dryness, maceration, tenderness, or open areas


name: Provide information regarding the relationship between neuropathy, injury, and vascular disease and the risk for ulceration and lower extremity amputation in persons with diabetes


name: Assist parents to set up routine for infant stimulation


name: Acknowledge patient's knowledge of medications


name: Monitor for potential complications associated with pacemaker insertion (e.g., pneumothorax, hemothorax, myocardial perforation, cardiac tamponade, hematoma, PVCs, infections, hiccups, muscle twitches)


name: Establish trust, safety, and the right to gain access to carefully guarded trauma material by monitoring reactions to the disclosure


name: Identify factors that contribute to incontinence episodes


name: Create a social setting for food consumption, as appropriate


name: Beta-2 Glycoprotein Antibody Measurement


name: Gel, Multi Ingredient Topical application Gel/Jelly [RADIAPLEXRX]


name: {35 (dexamethasone 1.5 MG Oral Tablet) } Pack


name: elastic bandage 1" X 2.2 yard TOPICAL BANDAGE


name: nutritional therapy, phenylketonuria (PKU) no.8


name: Monitor for self-reports of impending doom


name: Note any masses, including location, shape, size (in cm), tenderness, mobility, and consistency


name: Warm the site for approximately 5 minutes if specimen is to be an arterialized sample, according to agency protocol


name: Provide support for decisions made by caregiver


name: Request that your attorney explain the deposition process


name: Monitor catheter exit site for migration


name: Explore with patient what has triggered emotions


name: Assist patient or patient's family to arrange cards, flowers, and gifts to enhance the patient's visual appreciation


name: Provide documentation to meet agency guidelines


name: Monitor baseline and follow-up vital signs, as appropriate


name: Obtain verbal consent for use of aromatherapy


name: Inform client/family about the policy and procedures for carrying and administration of asthma medications at school


name: Document baseline measurements in clinical record


name: Establish a written plan with the client for managing exacerbations


name: Use a padded circumcision seat for infants


name: Ensure that the patient (or the legal designee if the patient is unable to give informed consent) has adequate understanding of ECT when the physician seeks informed consent to administer ECT treatments


name: Document the time elapsed, as well as the type and amount of movement, during the seizure


name: Provide emotional support to the patient, as needed


name: Ensure that patient is wearing an identification band


name: Encourage individual to begin or continue exercise


name: Demonstrate proper body alignment (posture) and lift form for exercising each major muscle group


name: Assist patient to express own beliefs, values, and goals for muscle fitness and health


name: Assist to develop a strength training program consistent with muscle fitness level, musculoskeletal constraints, functional health goals, exercise equipment resources, personal preference, and social support


name: Encourage patient to use cane or walker, as appropriate


name: Modify initial client assessment questions and history to be inclusive of exposure risk and physical symptoms of exposure


name: Teach patient/family about time frame for resolution of constipation


name: Obtain consensus from the staff for the family's presence and the timing of the family's presence


name: Communicate information concerning the patient's current status in a timely manner


name: Encourage consultation with other health care professionals, as appropriate


name: Determine reason for choosing hormone replacement therapy


name: Review information regarding interaction effects of adjunct therapies (e.g., calcium and vitamin D supplementation, exercise, thiazide use)


name: Instruct patient to wear a medical alert tag


name: Provide assistance in obtaining necessary financial resources (e.g., contact social services), as appropriate


name: Contact health professional/agency, as appropriate, to arrange for specialty foot care services (i.e., schedule an appointment)


name: Provide patient, family, or significant others with information about recommended specialty foot care services


name: Inspect skin for evidence of poor hygiene


name: Position patient supine or sitting in a chair with neck slightly hyperextended; ask patient to look at ceiling


name: Verify placement and patency of IV catheter within vein


name: Discard old, discontinued, or contraindicated medications, as appropriate


name: Complete a nutritional assessment, as appropriate


name: Instruct individual to perform muscle tightening exercises, working up to 300 contractions each day, holding the contractions for 10 seconds each and resting at least 10 seconds between each contraction, per agency protocol


name: Teach patient to monitor self for signs and symptoms that indicate need for medical treatment (e.g., fever, bleeding, respiratory distress, irregular pulse, cloudy outflow, and abdominal pain)


name: Assist the patient to obtain the appropriate light source for the treatment


name: Modify the treatment, as ordered, to decrease/eliminate side effects


name: Encourage individual to participate in PMS support group if available


name: Evaluate available support systems (e.g., extended family, community involvement, religious affiliations)


name: Include the individual in relocation plans, as appropriate


name: Assist the person to address painful, angry, or other negative memories


name: Assist patient to identify abilities and learning styles


name: Determine whether individual's monthly income is sufficient to cover ongoing expenses


name: Verify that individual is able to open medication containers


name: Introduce the patient to the concept of self-hypnosis as a therapeutic modality


name: Monitor for signs of infection (e.g., fever, pain) and other postoperative complications


name: Instruct patient that smoking decreases blood supply to the graft-recipient bed interface, increasing chances of graft failure, and thus should be avoided


name: Avoid friction and shearing forces at new graft site


name: Place on incontinence pads, as appropriate


name: Monitor patient's readiness to attempt to quit smoking


name: Instruct patient on the physical symptoms of nicotine withdrawal (e.g., headache, dizziness, nausea, irritability, and insomnia)


name: Encourage participation in interactions with family members, friends, and others


name: Obtain advance care directive information (i.e., Living Will and Durable Power of Attorney for Healthcare)


name: Assign caregiver of same sex, if available


name: Avoid rapid transportation to the bathroom


name: Contact your employer and malpractice carrier, as appropriate, when notice of deposition or subpoena for testimony is received


name: Answer only the questions asked and do not volunteer any unsolicited information


name: Provide information about what community resources and outreach programs are available


name: Determine adequacy of patient's financial situation


name: Advise regarding appropriate self-care measures for minor foot problems


name: Instruct to hydrate the skin daily by brief soaking or bathing in room-temperature water followed by application of an emollient


name: Monitor blood pressure at specified intervals and with changes in patient condition


name: Instruct patient and family member(s) regarding symptoms to report (e.g., dizziness, fainting, prolonged weakness, nausea, palpitations, chest pain, difficulty breathing, discomfort at insertion or external electrode site, electrical shocks)


name: Use developmentally appropriate language to ask about the trauma


name: Use relaxation and desensitization procedures to assist the child to describe the event


name: Assist appropriate others to provide support


name: Assist patient to identify patterns of incontinence


name: Recognize that weight loss may be part of the natural progression of a terminal illness (e.g., cancer)


name: cystine 0.5 gram-15 kcal/4 gram ORAL PACKET (EA)


name: diphencyprone 98 % MISCELL POWDER (GRAM)


name: mechlorethamine HCl 98 % MISCELL POWDER (GRAM)


name: Inspect the breasts for size, shape, changes in skin texture or color, including any redness, dimpling, puckering, scaling, or retraction of the skin


name: Send specimen to laboratory, as necessary


name: Minimize anxiety for the patient using age-appropriate procedures


name: Acknowledge difficulties of caregiving role


name: Correct the opposing lawyer, particularly if facts are misstated


name: Avoid mechanical compression of patient's limbs near central dialysis catheter


name: Make supportive or empathetic statements


name: Change insertion site and infusion tubing according to agency protocol


name: Block the patient's view of the bathroom, commode, or other equipment used for elimination


name: Confirm date and time of transfer to home


name: Participate in data collection related to incidence and prevalence of exposure to environmental hazards


name: Monitor closely animal visits with patients with special conditions (e.g., open wounds, delicate skin, multiple IV lines, or other equipment)


name: Monitor for contact dermatitis associated with possible allergy to essential oils


name: Instruct individual on purposes and application of aromatherapy, as appropriate


name: Compare current status with previous status to detect changes in respiratory status


name: Establish a regular schedule of follow-up care


name: Determine the ankle-brachial index (ABI), as appropriate


name: Use a radiant warmer to maintain body temperature during the procedure


name: Administer intravenous fluids, as ordered


name: Provide emotional support to patient and/or significant others, as needed


name: Encourage patient to verbalize feelings about the experience of ECT


name: Record patient's height and weight in the medical record


name: Suction oropharyngeal secretions, as needed


name: Determine individual's motivation to begin/continue exercise program


name: Develop ways for patient to participate safely in leisure activities


name: Inform patient of laws and services relevant to abuse


name: Become familiar with signs and symptoms and common onset presentations of clients exposed to bioterrorism agents


name: Consider the reliability of information, especially in emergencies, potential disasters, or mass exposures


name: Suggest use of laxative/stool softener, as appropriate


name: Use the patient's name when speaking to the family


name: Obtain information concerning the patient's status, response to treatment, identified needs


name: Escort the family from the bedside if requested by the staff providing direct care


name: Provide estimates of patient's risk based upon phenotype (patient characteristics), family history (pedigree analysis), calculated risk information, or genotype (genetic testing results)


name: Share concerns of patient or family with other health care providers


name: Inform patient of right to change health care provider


name: Facilitate the decision to continue/discontinue


name: Question patient or appropriate other about allergies to foods such as bananas, kiwi, avocado, mango, and chestnuts


name: Determine patient's financial resources for payment for specialty foot care services


name: Monitor level of protective sensation using Semmes-Weinstein nylon monofilament


name: Determine ankle pressure index, as indicated


name: Determine vibration perception threshold


name: Mark tubing as either intrathecal or epidural, as appropriate


name: Encourage the patient to have screening tests to determine medication effects


name: Identify and correct with the patient errors in orientation


name: Instruct person to brush teeth, gums, and tongue


name: Maintain confidentiality of patient health information


name: Avoid excess mechanical stress on peritoneal dialysis catheters (e.g., coughing, dressing change, infusing large volumes)


name: Support the patient's use of the treatment


name: Identify real or perceived barriers to family planning services and prenatal care and ways of overcoming barriers


name: Provide support, encouragement, and empathy for participant(s)


name: Share observation or thoughts about patient's behavior or response


name: Determine whether physical or cognitive ability is stable or declining, and respond to changes in either accordingly


name: Provide for methods of contacting support and assistance people (e.g., lifeline; list of telephone numbers for police, fire, poison control, and assistance people)


name: Obtain visual safety devices or techniques (e.g., painting edges of steps bright yellow, rearrange furniture for safety when walking, reduced clutter throughout walkways of house, nonskid surfaces installed in showers and bathtubs)


name: Monitor the patient's response to self-hypnosis on an ongoing basis


name: Incorporate moist wound healing techniques for skin autografts


name: Instruct the patient to keep the affected part immobilized as much as possible during healing


name: Limit patient activity to bed rest until graft adheres


name: Assist patient to develop practical methods to resist cravings (e.g., spend time with nonsmoking friends, frequent places where smoking is not allowed, relaxation exercises)


name: Arrange to maintain frequent telephone contact with patient (e.g., to acknowledge that withdrawal is difficult, to reinforce the importance of remaining abstinent, to offer congratulations on progress)